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Summary 
DNA methylation is an epigenetic mark that is indispensable for mammalian development and occurs at cytosine 
residues throughout the genome (the “methylome”). Approximately 70% of all CpG dinucleotides are affected by 
DNA methylation, which serve to “lock in” chromatin states and thus transcriptional programs.  The systemic and 
pervasive occurrence of DNA methylation throughout the genome defines cellular identity and therefore requires 
genome-wide assays to fully appreciate and discern differential patterns of methylation that influence aspects of 
phenotypic plasticity including susceptibility to common complex disease.   
One method that permits methylome analysis is methylated DNA immunoprecipitation (MeDIP) combined with next 
generation sequencing (MeDIP-seq). MeDIP uses an antibody raised against 5-methylcytosine to capture methylated 
fragments of DNA, which are subsequently sequenced to envisage the methylome landscape.  The advantageous cost 
versus coverage balance of MeDIP-seq has made it the method of choice to replace or complement array-based 
methods for population epigenetic studies. Here we detail nano-MeDIP-seq, which allows methylome analysis using 
nanogram quantities of starting material. 
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1. Introduction 
DNA methylation is the presence of a methyl group at the carbon-5 position of the cytosine pyrimidine ring, catalysed 
by DNA methyltransferases (1) forming 5-methylcytosine.  DNA methylation is present throughout the genome in a 
tissue- and cell-specific fashion and its presence effectively “locks in” transcriptional programs dictated primarily by 
the local chromatin state.  DNA methylation localises to all inter- and intra-genic features and, depending on where it 
occurs, can alter transcription both quantitatively (gene expression) and qualitatively (e.g., alternative splicing).  There 
are a number of mechanisms by which DNA methylation achieves these effects and these are being discovered at an 
ever-increasing rate (see Ref. 2 for a review). The sequence context in which DNA methylation affects cytosines can 
be largely divided into two categories: at CG dinucleotides (‘mCG’) and non-CG dinucleotides (‘mC’). Post 
implantation, approximately 60–80% (16.5M-22.5M) of CG dinucleotides are methylated in all nucleated human cells, 
including stem cell populations (3-5).  In embryonic pluripotent stem cells however, an additional 7.5M cytosines are 
methylated at non-CG dinucleotides (3;5), which permits a myriad of additional regulatory controls to achieve diverse 
cellular phenotypes.  
Given that DNA methylation is distributed genome-wide, and that patterns of this distribution vary both within- and 
between- individuals for matched cell types, comprehensive and systematic assays are required.  A number of 
technologies exist to meet this need (reviewed in Ref. 6), including Methylated DNA immunoprecipitation or 
‘MeDIP’.  MeDIP involves antibodies directed against mC or mCG to precipitate methylated DNA fragments. MeDIP 
is able to detect methylated cytosines in both mC and mCG contexts, and a major benefit is that it is capable of 
targeting the vast majority of the methylome. 
Because antibodies used for MeDIP were raised in a way to yield equal specificity against mC and mCG, MeDIP 
offers a hypothesis-free approach without prior assumptions about which regions of the methylome might be targeted. 
The most information-rich way of capitalising on the largely balanced qualities of MeDIP has been to combine it with 
next-generation sequencing, or MeDIP-seq (7). This application provides high-quality methylomes at typically 100- to 
300-bp resolution (depending on chosen insert size) at costs comparable to other capture-based techniques (8) and was 
used to generate the first methylome of any mammalian genome (7).  
One limitation of MeDIP-seq concerns genomic resolution. Although single–base pair resolution is desirable, we feel 
that the resolution offered by MeDIP-seq offsets issues of coverage and cost associated with single-base pair (e.g., 
bisulfite treatment) sequencing-oriented technologies. We also consider 150–200 bp to be a suitable resolution for 
most applications, as DNA methylation at adjacent CpGs is correlated for up to approximately 1 kb (9). 
Another limitation of MeDIP-seq is that methylated DNA recovery by the antibody is affected by mC/mCG density, 
such that regions of very low (<1.5%) density may be underrepresented or even interpreted as unmethylated. 
Furthermore, MeDIP enriches only for methylated portions of the genome, and unmethylated portions can only be 
inferred by an absence of reads. Consequently, the confidence placed on this inference is highly dependent on 
sequencing depth; the cost of this however, is continually falling (10) and may cease to become a limiting factor in the 
future. 
In addition to being a cost-effective method for analyzing all currently known forms of mammalian DNA methylation, 
the MeDIP-seq protocol has the advantage that as little as 50ng DNA can be used (11). This makes MeDIP-seq 
suitable for studies involving minute clinical samples, microdissected tissues and rare cell types. 
In our laboratory, MeDIP-seq libraries can be created in three days; however, inexperienced users might prefer to 
spread the protocol over five days. The time required for the actual sequencing depends on the model of the sequencer 
(at the time of writing an Illumina HiSeq 2500 takes ~5.5 days for a ‘high output’ paired-end run of 50 bases).  




1. 1 M Tris-HCl (pH 7.8) 
2. 1 M Tris-HCl (pH 8.0) 
3. 1 M Tris-HCl (pH 8.5) [Elution buffer] 
4. 0.5 M EDTA solution  
5. 5 M NaCl: Dissolve 292.2 g of NaCl in 1,000 ml of PCR grade water. Store at room temperature and use within 2 
years. 
6. 1× sodium chloride-Tris-EDTA (STE) buffer: Mix 100 μl 1 M Tris-HCl (pH 7.8), 20 μl 0.5 M EDTA, and 100 μl 
5 M NaCl in a total volume of 10 ml (fill up with PCR grade water). Store at room temperature and store 
indefinitely. Final concentrations: 10 mM Tris-HCl, 1 mM EDTA and 50 mM NaCl. 
7. 1× Tris-EDTA (TE) buffer: Mix 10 ml 1 M Tris-HCl (pH 8.0), 2 ml 0.5 M EDTA in a total volume of 1 l (fill up 
with PCR grade water). Store at room temperature and store indefinitely. Final concentrations: 10 mM Tris-HCl, 1 
mM EDTA. 
8. Lambda (λ)-DNA (NEB, cat. no. N3011S) for methylated control fragments (See Note1) 
9. SssI CpG methyltransferase (NEB, cat. no. M0226S) 
10. Taq DNA Polymerase with 10x Buffer containing 15 mM MgCl2 (ABgene, cat no. AB-0192/A) 
11. Agencourt Ampure XP (60 ml; Beckman Coulter, cat. no. A63881) 
12. Library Preparation End repair module (NEB, cat. no. E6050L) 
13. Library Preparation A-tail module (NEB, cat. no. E6053L) 
14. Library Preparation Adapter ligation module (NEB, cat. no. E6056L) 
15. Auto-MeDIP kit [Diagenode, cat. no. AF-Auto01-0016 (16 reactions) or AF-Auto01-0100 (100 reactions)].  See 
Note2. 
16. High-fidelity PCR kit (Kapa Biosystems, cat. no. KK2101) 
17. Gel DNA Recovery Kit (Zymo Research, cat. no. D4001) 
18. 96-100% Ethanol 
19. 70% Ethanol 
20. Agarose  
21. 50bp DNA Ladder (see Note3) 
22. 10× Tris Borate EDTA (TBE) 
23. Ethidium bromide (10mg/ml)  
24. Gel loading dye containing bromophenol blue, xylene cyanol, and orange G 
25. DNA1000 kit (Agilent, cat. no. 5067-1504) 
26. High-Sensitivity kit (Agilent, cat. no. 5067-4626) 
27. SYBR qPCR master mix 
28. PCR grade water  
29. Paired-end (PE) sequencing adapters (see Note4). Spin down lyophilized adapter oligos in a chilled (4 °C) 
microcentrifuge at 200g for 5 min.  Resuspend each oligo in 1× STE buffer to 100 μM. Add equimolar quantities 
of each adapter into a 1.5 ml microcentrifuge tube. Divide into small (e.g., 200 μl) aliquots and incubate at 95 °C 
for 15 min, and then leave to cool down to room temperature (~1 h). Store aliquots at −20°C until required. Final 
concentration: 50 μM.  
30. Adapter-mediated PCR primers (see Note5). Spin down lyophilized primer oligos in a chilled (4 °C) 
microcentrifuge at 200g for 5 min. Resuspend each oligo in Elution buffer to create 100 μM stocks. Dilute 
aliquots tenfold in 1 × TE buffer to create 10 μM dilutions. Store dilutions in manageable volumes at − 20 °C until 
required.  
31. Quality Control (QC) primers (see Note6).  
 
2.2. Equipment 
1. Microcentrifuge tubes (0.5 ml, 1.5 ml & 2 ml) 
2. 8-strip, 0.2 ml PCR tubes and caps  
3. 12-strip, 0.2 ml PCR tubes and caps 
4. IP-Star tips (Diagenode, cat. no. WC-001-1000) 
5. qPCR plates and seals 
6. Centrifuge with 0.2 ml tube adapter (‘microfuge’) 
7. Centrifuge with 2.0 ml adaptors  
8. Pipettes 
9. Pipette filter tips 
10. Vortex 
11. Transilluminator and imaging software  
12. Microwave oven 
13. Magnetic separation rack 
14. Scalpels  
15. Thermocycler  
16. qPCR system  
17. Gel electrophoresis system (inc. gel tanks and combs) 
18. Weighing scale and weighing boats 
19. Sonicator (see Note7) 
20. Heat block or oven 
21. Agilent Bioanalyzer 2100  
22. Illumina sequencer (see Note8) 
23. SX-8G IP-Star (see Note9)  
 
3. Methods 
Before creating MeDIP-seq libraries, it is worth spending time familiarising oneself with the workflow (see Figure 1). 
 
3.1. Creation of methylated and unmethylated controls 
The following describes a one-off set of procedures to create a central laboratory resource of methylated and 
unmethylated control fragments that should be suitable for over a million MeDIP assays. 
1. For each control region, combine the following reagents in a 0.2 ml PCR tube (note, it is often more convenient 
to make a mastermix excluding primers): 
Reagent ×1 reaction 
10× Reaction buffer IV  2.5 µl 
MgCl2 (25 mM) 1.0 µl 
dNTP mix (20 mM) 1.0 µl 
Forward primer (see Table 1) 1.25 µl 
Reverse primer (see Table 1) 1.25 µl 
PCR grade water 17.625 µl 
λ-DNA (0.0005 ng/µl) 1.0 µl 
Taq DNA polymerase 0.125 µl 
Total Volume/Reaction 25.0 µl 
 
 
2. Pipette mix and briefly centrifuge in a microfuge to consolidate reactions 
3. Setup and run the following PCR program: incubate for 2 min at 94 °C, followed by a total of 40 cycles of (20 s 
at 94 °C, 30 s with touchdown: 53/65°C, 60 s at 72°C), then 5 min at 72°C 
4. Purify amplicons using 1.8 volumes Ampure XP purification beads according to manufacturer’s procedure (see 
Note10) and elute in 10 µl Elution buffer.   
5. Run the sample on an Agilent Bioanalyzer 2100 using DNA1000 chips and reagents according to manufacturer’s 
instructions. Verify DNA fragment size range and concentration using the instrument’s software.  
6. Divide each amplicon into two aliquots and label. 
7. Set up one in vitro methylation reaction and one control reaction for each aliquot in a 0.2 ml PCR tube as follows 
and incubate for 2 hrs at 37°C, followed 20 mins at 65°C: 
Reagent in vitro methylation reaction control reaction 
PCR grade water 10.0 µl 11.0 µl 
10× NEBuffer 2 2.0 µl 2.0 µl 
S-adenosylmethionine (1.6 mM) 2.0 µl 2.0 µl 
Amplicon DNA (from step 4) 5.0 µl 5.0 µl 
SssI methyltranserferase (4 U/µl) 1.0 µl -- 
Total Volume/Reaction 20.0 µl 20.0 µl 
 
 
8. Purify each reaction using 1.8 volumes Ampure XP purification beads according to manufacturer’s procedure and 
elute in 10 µl Elution buffer. 
9. Each amplicon contains at least one 5’-ACGT-3’ motif, which allows the methylation status of each region to be 
verified using the methylation sensitive enzyme, HpyCH4IV. To do so, dilute 1 µl of each amplicon from each 
reaction 1 in 10 with PCR grade water 
10. Set up the following reaction for each diluted DNA incubate for 1 hr at 37°C then 20 min at 65°C: 
Reagent ×1 reaction 
10× NEBuffer 1 2.5 µl 
HpyCH4IV (10 U/µl) 1.0 µl 
diluted DNA 10 µl 
PCR grade water 11.5 µl 
Total Volume/Reaction 25.0 µl 
 
11. Purify each sample using 1.8 volumes Ampure XP purification beads according to manufacturer’s procedure and 
elute in 10 µl Elution buffer. 
12. Run the sample on an Agilent Bioanalyzer 2100 using DNA1000 chips and reagents according to manufacturer’s 
instructions. Validate DNA fragment size range and concentration using the instrument’s software. See Note11. 
13. Create 1 nM working dilutions of methylated and unmethylated controls based on Bioanalyzer readings  
14. Use the 1 nM dilutions to create a equimolar cocktail of control fragments consisting of methylated (0.5%, 3.7%, 
5.6%, 6.5% and 10% CpG density) and unmethylated (14.5% CpG density) fragments 
15. Store stock solutions and working dilutions (e.g., 10µM) of in vitro methylated and unmethylated fragments at -
20°C indefinitely 
16. Run the sample on an Agilent Bioanalyzer 2100 using DNA High Sensitivity chips and reagents according to 
manufacturer’s instructions. Validate DNA fragment size range and concentration using the instrument’s 
software. See Note12. 
17. Dilute the cocktail in 1×TE buffer to create a 100pM (each) stock cocktail 
18. Dilute aliquots of the 100 pM stock in 1× TE buffer to create working dilutions of 0.19 pM (or ~ 114,000 copies 
per µl). See Note13. 
 
3.2. DNA Fragmentation 
1. In a 0.5 ml or 1.5 ml microcentrifuge tube, resuspend gDNA in 85 µl Elution buffer. 
2. Pre-chill the sonicator water bath by filling with ice and leave for 15 min. 
3. After 15 min, replace the ice in the water bath with ice-cold water. 
4. Place microcentrifuge tube containing DNA in the appropriate tube holder, making sure the holder is balanced. 
5. Set sonicator to ‘High’ and sonicate for 15 min consisting of 30-sec on/off periods. 
6. Following 15 min cycle, briefly centrifuge DNA samples and store on ice.  
7. Cool the sonicator for 5-10 min by filling with crushed ice. 
8. Repeat steps 5-7 up to another six times (see Note14) 
9. Run the sample on an Agilent Bioanalyzer 2100 using High Sensitivity DNA chips and reagents according to 
manufacturer’s instructions; validate DNA fragment size range and concentration using the instrument’s 
software15.  
 
3.3. Library Preparation (1 of 2)  
1. DNA end repair. Mix the following on ice in a sterile PCR tube and incubate for 30 mins at 20°C. Scale 
accordingly. 
Reagent ×1 reaction 
NEBNext End Repair Enzyme mix 5 µl 
NEBNext End Repair Reaction Buffer (10X) 10 µl 
Fragmented DNA  85 µl 
Total Volume 100 µl 
 
2. Place the reaction on ice after incubation, spin briefly in a microfuge for ~3 s to collect condensate. 
3. Purify DNA sample using 1.8 volumes Ampure XP purification beads according to manufacturer’s procedure and 
elute in 37 µl Elution buffer.   
4. dA-tailing. Mix the following on ice in a sterile PCR tube and incubate for 30 mins at 37°C (see Note16). Scale 
accordingly. 
Reagent ×1 reaction 
Klenow Fragment (3’ → 5’ exo-) 3 µl 
NEBNext dA-tailing Reaction Buffer (10X) 5 µl 
PCR grade water  5ul 
Purified End-Repaired, blunt-ended DNA  from Step 3 37 µl 
Total Volume 50 µl 
 
5. Purify DNA sample using 1.8 volumes Ampure XP purification beads according to manufacturer’s procedure and 
elute in 25 µl Elution buffer. 
6. Calculate the reaction concentration of DNA adapters to be used in the adapter ligation reaction (see Note17) 
7. Adapter ligation. Mix the following on ice in a sterile PCR tube and incubate in a thermocycler for 2 h at 18°C. 
Scale accordingly. 
Reagent ×1 reaction 
Quick Ligation Reaction Buffer (5x) 10 µl 
Adapters  Variable 
PCR grade water to 50 μl As required 
End Repaired, Blunt, dA- Tailed DNA from Step 5 25 µl 
Quick T4 DNA Ligase 5 µl 
Total Volume 50 µl 
 
8. Purify DNA sample using 1.8 volumes Ampure XP purification beads according to manufacturer’s procedure and 
elute in 40 µl Elution buffer. 
9. Run 1 µl of eluted sample on an Agilent Bioanalyzer 2100 using High Sensitivity DNA chips and reagents 
according to manufacturer’s instructions; determine the concentration of the full range of DNA fragments (see 
Note18).   
 
3.4 Methylated DNA Immunoprecipitation 
1. Perform MeDIP on purified adapter-ligated DNA from Step 8 (previous section), using the Diagenode Auto-
MeDIP and SX-8G IP-star (see Note2 and Note19). 
2. Antibody (Ab) Dilution. Mix the following on ice and scale accordingly (see next step):  
Reagent vol 
Antibody 1 µl 
PCR grade water 15 µl 
Total Volume 16 µl 
 
3. Antibody Mix. Mix the following on ice: 
Reagent ×1 IP 
Diluted Ab (from Step 2) 2.40 µl 
MagBuffer A (5X) 0.60 µl 
MagBuffer C 2.00 µl 
Total Volume 5.00 µl 
 4. 1 × Magbuffer A. Gently mix the following on ice and scale accordingly: 
Reagent ×1 IP 
MagBuffer A (5X) 30 µl 
PCR grade water  120 µl 
Total Volume 150 µl 
 
5. Incubation Mix. Mix the following (sufficient for 1× IP and 1× Input) on ice and scale accordingly: 
Reagent ×1 IP 
MagBuffer A (5X) 24 µl 
MagBuffer B 6 µl 
Lambda Spike cocktail (0.2 µM each; see Note1) 3 µl 
Purified Adapter Ligated DNA Variable 
PCR grade water up to 90 µl As required 
Total Volume/reaction 90 µl 
 
6. Incubate Incubation Mix(es) at 99°C for 10 min. 
7. Snap cool on ice for 10 min. 
8. Switch on the IP Star (see Note20).  
9. Mix the Incubation Mix(es) by pipetting up and down and spin for 3 sec on microfuge. 
 
The following steps detail the loading of the IP-Star (a description of the automated process is presented in Note21).   
 
10. Load reagents into a 12-strip tube as per Figure 2 (1 strip tube per IP):  
11. Place the filled 12-strip on the Peltier block(s) (see Figure 3, black-boxed zone and Note22, Note23, and Note24).   
12. Place IP Star tips into tip rack (see Figure 3, red-boxed zone; see Note25). 
13. Double click a tip rack in the GUI until it shows tips are present. The clicked tip rack should correspond to the tip 
rack just filled. 
14. Select 8IPs or 16IPs protocol for 8 and 16 MeDIP reactions respectively. 
15. Click ‘Modify’ to set IP incubation time and temperature (see Note26).  
16. Press Start and OK the confirmation screen that appears: The automated MeDIP reaction starts. After the IP Star 
has eluted the mDNA-Ab-bead complex in DIB solution, a dialog box appears on the screen.  
17. Add 1 μl proteinase K (from AutoMeDIP kit) to well 1 and well 12 for each 12 strip. 
18. Add 7.5 μl Input DNA into well 1 of the 12-strip. 
19. Cap the 12-strip. 
20. OK the dialog box and close the IP Star door. 
21. OK the dialog box; the proteinase K digestion reaction will start. 
22. Once completed, a confirmation message appears in the GUI: Remove samples from the IP Star and transfer the 
contents of well 12 (proteinase K digested IP reaction) into clean 0.2 ml PCR tubes and collect the magnetic 
beads on a magnetic rack (see Note27). 
23. Shut down the IP Star software and turn off the IP Star off. 
 
3.5 Quality Control: test for recovery of spiked-in λ-DNA and specificity of the MeDIP 
reaction (QC 1) 
 
1. Prepare the following on ice in a qPCR plate: perform each reaction in triplicate for methylated and unmethylated 
control regions (see Table 1). 
Reagent ×1 reaction 
2x SYBR qPCR master mix 6.25 µl 
Primer Pair (10 μM) 0.625 μl 
PCR grade water 4.375 µl 
MeDIP or Input DNA (from Step 22 of previous section) 1.25 µl 
Total Volume/Reaction 12.5 µl 
 
2. Seal plate and centrifuge briefly to ensure no bubbles remain at the bottom the wells. 
3. Run the following program on the real time PCR machine: 1) 95°C for 5 min, 2) 40 cycles of 95°C for 15 s, 60°C 
for 1 min, C) meltcurve. 
4. Calculate Recovery and Specificity (see Note28).  
 
For troubleshooting problems associated with the MeDIP reaction see Table 2. 
 
3.6 Library Preparation (2 of 2) 
1. Purify DNA sample (from Step 22 of section 3.4) using 1.8 volumes Ampure XP purification beads according to 
manufacturer’s procedure and elute in 25 µl Elution buffer 
2. Adapter-mediated PCR (amPCR). On ice, mix and scale accordingly the following in a sterile PCR tube. Pipette 
up and down to mix. 
Reagent ×1 reaction 
5X KAPA GC Buffer 10 μl 
10 mM dNTP Mix 1.5 μl 
Forward primer (10 µM) 5 µl 
Reverse primer (10 µM) 5 µl 
DMSO 2.5 μl 
Purified MeDIP DNA (from Step 1) 25 µl 
1 U/µl KAPA HiFi Polymerase 1 μl 
Total Volume 50 µl 
 
3. Split each reaction into two 25 μl aliquots and perform PCR in a preheated thermocycler, using the following 
cycling conditions: 1) 95°C for 2 min, 2) 8-13 cycles of: 98°C for 20 s → 60°C for 15 s → 72°C for 15 s, C) 
72°C for 5 min. 
4. Combine the two PCR MeDIP reactions and purify DNA sample with 1.8 volumes Ampure XP purification beads 
and elute in 15µl Elution buffer (see Note29). 
5. Run 1 µl of eluted sample on an Agilent Bioanalyzer 2100 using DNA1000 chips and reagents according to 
manufacturer’s instructions; validate DNA fragment size range using the instrument’s software. For 
troubleshooting see Table 2. 
6. Prepare a 2% TBE agarose gel, with 0.5 μl/ml Ethidium Bromide (see Note30). 
7. Mix the remaining PCR amplified MeDIP reactions (from Step 4) with an appropriate volume of loading dye and 
load on gel, leaving space either side for ladders (see Note30). 
8. Load 1 μg of a 50 bp DNA ladder in wells flanking the DNA sample.   
9. Carry out gel electrophoresis in freshly prepared 1 × TBE buffer at 100 volts until orange G dye runs off gel. 
10. Following gel electrophoresis, carefully transfer gel onto a UV transilluminator. 
11. With a clean scalpel, excise the desired 50 bp library size range31. Ensure the gel slice is cut as close to DNA 
smear as possible (see Note32). See Note33. 
12. Purify DNA libraries using Gel DNA Recovery Kit (Zymo Research) according to manufacturer’s protocol and 
elute in 10 µl Elution buffer.  
13. Assess 1 µl of size selected DNA on an Agilent Bioanalyzer using High Sensitivity DNA chips and reagents 
according to manufacturer’s instructions to determine gel extraction has worked. 
 3.7 Quality Control: test for enrichment of methylated regions (QC 2) 
1. Dilute 1 µl of size selected DNA to 9 µl with PCR grade water and validate the enrichment of genomic regions of 
known methylation status (see Table 1 and Note6) by qPCR using reaction setup as detailed in Steps 1-2 of 
section 3.6. 
2. Calculate enrichment as described Note34. For troubleshooting see Table 2. 
 
3.8 Next generation sequencing and bioinformatic processing 
1. Subject sample to next generation sequencing with an Illumina machine that uses flowcells compatible with the 
primer sequences used during amPCR according to manufacturer’s instructions. 
2. Use FastQC (http://www.bioinformatics.bbsrc.ac.uk/projects/fastqc/) to perform quality control of the reads.   
3. Align MeDIP-seq reads to the relevant reference genome using BWA (see Note35 and Note36). 
4. Use BWA to run ‘bwa aln’ on both read ends to generate two .sai output files. 
5. Use BWA to run ‘bwa sampe’ using the .sai files from previous Step as input; the output is a SAM formatted 
alignment file.  
6. Use SAMtools to discard reads from the SAM formatted alignment file that fail to map as a proper pair. 
7. Use MeDUSA to discard read pairs in which neither read scored a BWA alignment score ≥ 10.  
8. Use MeDUSA to identify groups of non-unique reads (i.e. ‘clonal reads’ – reads that align to the exact same start 
and stop position on the same chromosome) to discard all but one read from the group. 
9. Perform MeDIP-seq specific QC on the filtered data from previous Step using MeDIPs. 
4. Notes
                                                     
1 The construction of six λ-DNA fragments of varying CpG content is described in Box 1 of Ref. (11) 
2 MeDIP can also be performed manually using, e.g., the MagMeDIP kit (Diagenode, cat. no. mc-magme-A10) or 
other kits/reagents. In this case, we advise taking care with respect to accurate and consistent timing of incubation 
steps, as well as performing lengthy and thorough bead washing steps. 
3 To increase the accuracy of gel excision we advise using a ladder with molecular-weight standards ranging from 50 
to 700 bp in 50-bp size intervals. 
                                                                                                                                                                                               
4 Depending on the experimental design, single-plex or multiplex Illumina adapters can be created and ligated to 
fragmented DNA. Table 1 presents adapter sequences for single-plex and multiplex applications, although other 
adapter systems could be used (e.g., see seqanswers.com) providing they DO NOT contain methylated cytosines.   
5 Depending on the experimental design (e.g., single-plex or multiplex library construction), primers complementary 
to the appropriate Illumina adapters should be used. Table 1 presents primer sequences for single-plex and multiplex 
applications, although other primers compatible with other adapter systems can be used (e.g., see seqanswers.com). If 
multiplexing, always pool > 3 indexed samples for sequencing. 
6 For QC1, nested qPCR primers were designed for each λ-DNA fragment; sequences are presented in Table 1. For 
QC2, primers were designed to amplify regions of assumed methylation status in appropriate reference genomes, e.g., 
for previous work in humans see Ref. (13); we present example sequences for mouse and human in Table 1. Prepare 
and treat oligos as detailed in Note 5. 
7 We recommend using the Bioruptor (Diagenode) sonicator for DNA fragmentation; however, other methods can be 
applied provided these can generate the specified DNA fragment range and peak. 
8 The protocol detailed in these pages describes applications compatible with MiSeq, GAIIx and HiSeq instruments. 
9 We use the SX-8G IP-Star for our automated MeDIP-seq protocol, as it was specially designed and programmed for 
this purpose; however, generic liquid handlers can be programmed to carry out the MeDIP step as detailed in the 
MagMeDIP protocol (Diagenode). 
10 After the second ethanol wash, place the keep the tubes on the magnetic rack and heat in an oven at 55°C for about 
7 minutes to evaporate all the ethanol. When the bead pellet starts to crack, this is a good time to elute. 
11 In vitro methylated fragments will not be digested by HpyCH4IV and will result in intact, full length fragments that 
correspond to the length of the original amplicon; unmethylated fragments will be digested at the restriction site and 
show multiple fragment lengths 
12 The molarity of each fragment in the cocktail is expected to be 166 pM.  If not, correct accordingly by adding more 
of the required fragment(s) to normalize concentrations and re-check on a Bioanalyzer 2100 with High Sensitivity 
chips 
                                                                                                                                                                                               
13 For the vast majority of QC purposes we find that qPCR of just two regions [one methylated (10% CpG density) 
and one unmethylated (14% CpG density)] is sufficient to evaluate MeDIP.  However, the full range of fragments in 
the cocktail can be assayed if desired 
14 Fragmented DNA can be stored at -20°C for up to 1 month. 
15 We aim to create fragment the sample so the majority of fragments are below 500bp and that 25-30% of fragments 
are between 150-250bp. 
16 If using a thermocycler, use a heated lid (100°C) during all incubations involving temperatures over 30°C to prevent 
evaporation of samples. 
17 To achieve 10-fold excess molarity of adapters to DNA fragments in a 50 μl reaction, the following heuristic 









where ng is starting concentration of DNA, bp is average size of DNA fragments and r is estimated recovery from 
beads. For example, a starting concentration of 200ng DNA with average size of 180bp, assuming 0.8 (80%) recovery 
from beads will require a reaction concentration of adapters of approximately 431 nM. 
18 If multiple samples are being run, determine the concentration across a set size range of fragments (e.g., 240-290bp) 
using the ‘Smear Analysis’ feature of the Bioanalyzer software. Sample input (ng) can then be normalized across 
samples during MeDIP to maintain reaction stoichiometry. 
19 The following six steps deviate from the manufacturer’s instruction and represent optimized steps. 
20 The IP Star takes approximately 10 minutes to equilibrate to the appropriate temperature (4°C), so now is a 
convenient time to switch it on. 
21 The IP-Star (Diagenode) is capable of automating up to 16 MeDIPs per run.  Each run is split into two parts with a 
manual intervention step in between.  In the first part, the IP-Star washes the magnetic beads (to remove any 
preservatives), immunoselects and captures the methylated fraction, washes away unbound (unmethylated) DNA and 
elutes in a proteinase K buffer.  The second part requires the manual addition of input DNA well 1 and proteinase K to 
                                                                                                                                                                                               
wells 1 and 12; this is followed by two 15 min incubations at 55°C and 95°C, respectively; the Peltier block then cools 
to 4°C until the user removes the samples. A small proportion of these products are subject to quality control by qPCR 
(see below) and the rest are purified. The result is a pure methylated fraction ready for amPCR.   
22Peltier blocks and tip racks of the IP Star should be conceptualised as 96-well plates, i.e., 90° clockwise to the user. 
We call a row of 12 wells a ‘lane’ and the MeDIP protocol proceeds in the direction of the arrow so align Well 1 of 
the 12-strip tube with the beginning of the arrow. 
23 If running 8 or fewer IPs, load the 12-strips in the right-hand Peltier block. If running > 8 IPs, load the remaining 
12-strips in the left-hand Peltier block.  
24 If running > 8 IPs it is best to balance the workload across both Peltier blocks and mirror the layout between blocks.  
Therefore, if running an odd number of IPs > 8 we recommend placing an empty 12-strip on the Peltier block 
containing fewer samples, to mirror the formation of the Peltier block with more samples. 
25 Each IP lane in the Peltier Block should have a corresponding lane of IP Star tips in a tip rack. When performing 
eight or fewer IPs, load 6 IP Star tips per lane; if performing between 8-16 IPs, load 9 IP Star tips per lane. Tip lanes 
must correspond to sample lanes. 
26 IP incubation times are for each block. We recommend at least 7.5 hours incubation time (15 hrs is preferable) and 
4°C incubation temperature 
27 MeDIP and Input DNA can be stored at -20°C for up to 3 months and longer at -80°C 
28 From the qPCR results, ‘Recovery’ and ‘Specificity’ is calculated to evaluate MeDIP efficiency. Recovery, which is 
a measure of the MeDIP efficiency – indexed as percentage input – is calculated using the cycle threshold (Ct) of 
MeDIP and Input fractions from the qPCR reaction. Since only 10% of the DNA used in MeDIP is used for Input, the 









 Where AE is the % amplification efficiency expressed as a decimal (e.g., 100% AE = 1) and 10 represents the 
dilution factor of Input to MeDIP (i.e., 75 μl IP vs. 7.5 μl Input = x10). 
Recovery is then calculated for each set of primers as:  
                                                                                                                                                                                               
100x  
)Ct(CtAE
2 = (%)Recovery MeDIPinput

 













We consider MeDIP successful when specificity is ≥ 95% and that this has been derived from unmethylated recovery 
< 1%. 
29 Purified PCR products can be stored at -20°C for up to 3 months and longer at -80°C 
30 Multiple samples can be run on a single gel. However, maintain a minimum of 2cm (3 wells) between ladder and 
sample wells. 
31 We excise and purify 300-350bp libraries, which correspond to 180-230bp insert sizes. We also excise 250-300bp- 
and 350-400bp ‘contingency’ libraries. 
32 To prevent cross contamination of libraries, use a fresh scalpel for each library. 
33 Because UV exposure can be carcinogenic, wear protective clothing and UV resistant face shield. 
34 The aim of QC 2 is to verify the library insert remains enriched for methylated fragments and depleted for 
unmethylated fragments following amPCR and gel excision. In contrast to QC 1, QC 2 involves the qPCR of 
fragments from just the sample DNA.  This is because the λ-DNA fragments are not ligated to adapter sequences and 
evade amplification during amPCR. Calculate the fold-enrichment ratio for methylated vs. unmethylated regions:  
)CtCt( meth_MeDIPunmeth_MeDIPAE2Ratio Enrichment Fold

  
We recommend sequencing libraries if the fold-enrichment ratio exceeds 25, that is, the methylated fragments tested 
are 25-fold more enriched than the unmethylated fragments; we routinely see however, fold-enrichment ratios greater 
than 100 and higher scores are better. 
35 Prior to alignment, BWA should be used to index the reference genome using ‘bwa index’, using fasta files as input 
(the genomic fasta files are available from numerous public repositories including the UCSC Genome Browser 
(http://genome.ucsc.edu/)) 
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Table legends 
Table 1 Details of the oligos used in the protocol. CpG% is defined as 2×number CpGs / fragment length [bp]. For 
fragments derived from the fragmented sample DNA, CpG% was estimated by simulation.  Enterobacteria phage 
lambda genomic Start and Stop coordinates were derived from accession number NC_001416; human genomic start 
and stop coordinates were derived from reference assembly GRCh37.p2; mouse genomic start and stop coordinates 
were derived from reference assembly MGSCv37. [*] = phosphothiolate; [Phos] = 3’-phosphate. †Adapters and 
amPCR primers for single-plex library prep; ‡Adapters and amPCR primers for multiplex library prep. 
 
Table 2 Troubleshooting guide. 
 
Figure legends 
Figure 1 The MeDIP-seq workflow. MeDIP-seq libraries can be created in three days. The time required for the actual 
sequencing depends on the model of the sequencer (at the time of writing, an Illumina HiSeq 2500 takes ~5.5 days for 
a ‘high output’ paired-end run of 50 bases).  Bioinformatic processing takes approximately 10 hours. 
 
Figure 2 Reaction mixes for a single AutoMeDIP run.  Reagents are mixed and dispensed into 12-strip tubes prior to 
starting an AutoMeDIP run, at which point the IP-Star performs MeDIP sequentially across the wells.   
 
Figure 3 Layout of the IP-Star bed. The red-boxed zone illustrates the location of tip-holders; the black-boxed zone 
shows the two 96-well Peltier blocks.  The arrows demonstrate the direction of workflow of the IP-Star. Twelve 
consecutive wells are called ‘lanes’; when <=8 IPs are being performed, only the right Peltier block (lanes 1-8) is 
used; when >8 IPs are being performed, both blocks are used. It is important to match tips in lanes of tip racks with 












Adapter PE 1.0†  N/A [Phos]GATCGGAAGAGCGGTTCAGCAGGAATGCCGAG 33 N/A N/A N/A N/A 
Adapter PE 2.0† N/A ACACTCTTTCCCTACACGACGCTCTTCCGATC*T 32 N/A N/A N/A N/A 
Adapter InPE 1.0‡ N/A [Phos]GATCGGAAGAGCACACGTCT 20 N/A N/A N/A N/A 
Adapter InPE 2.0‡ N/A ACACTCTTTCCCTACACGACGCTCTTCCGATC*T 33 N/A N/A N/A N/A 
PCR.primer.PE.1.0 (F)† N/A AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATC*T 58 N/A N/A N/A N/A 
PCR.primer.PE.2.0 (R)† N/A CAAGCAGAAGACGGCATACGAGATCGGTCTCGGCATTCCTGCTGAACCGCTCTTCCGATC*T 61 N/A N/A N/A N/A 
PCR Primer InPE 1.0 
(F)‡ 
N/A AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATC*T 58 N/A N/A N/A N/A 
PCR Primer InPE 2.1 
(R)‡ 
N/A CAAGCAGAAGACGGCATACGAGATCGTGATGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T 64 N/A N/A N/A N/A 
PCR Primer InPE 2.2 
(R)‡ 
N/A CAAGCAGAAGACGGCATACGAGATACATCGGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T 64 N/A N/A N/A N/A 
PCR Primer InPE 2.3 
(R)‡ 
N/A CAAGCAGAAGACGGCATACGAGATGCCTAAGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T 64 N/A N/A N/A N/A 
PCR Primer InPE 2.4 
(R)‡ 
N/A CAAGCAGAAGACGGCATACGAGATTGGTCAGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T 64 N/A N/A N/A N/A 
PCR Primer InPE 2.5 
(R)‡ 
N/A CAAGCAGAAGACGGCATACGAGATCACTGTGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T 64 N/A N/A N/A N/A 
PCR Primer InPE 2.6 
(R)‡ 
N/A CAAGCAGAAGACGGCATACGAGATATTGGCGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T 64 N/A N/A N/A N/A 
PCR Primer InPE 2.7 
(R)‡ 
N/A CAAGCAGAAGACGGCATACGAGATGATCTGGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T 64 N/A N/A N/A N/A 
PCR Primer InPE 2.8 
(R)‡ 
N/A CAAGCAGAAGACGGCATACGAGATTCAAGTGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T 64 N/A N/A N/A N/A 
PCR Primer InPE 2.9 
(R)‡ 
N/A CAAGCAGAAGACGGCATACGAGATCTGATCGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T 64 N/A N/A N/A N/A 
PCR Primer InPE 2.10 
(R)‡ 
N/A CAAGCAGAAGACGGCATACGAGATAAGCTAGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T 64 N/A N/A N/A N/A 
PCR Primer InPE 2.11 
(R)‡ 
N/A CAAGCAGAAGACGGCATACGAGATGTAGCCGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T 64 N/A N/A N/A N/A 
PCR Primer InPE 2.12 
(R)‡ 








N/A 145 24004 24148 
1CpG_qPCR_R CCTATGAGCAACGTGTTAG 19 
5CpG_qPCR_F CACTTGAATCTGTGGTTCAT 20 
N/A 130 25942 26071 
5CpG_qPCR_R TAGAAAAAGACAACTCTGGC 20 
10CpG_qPCR_F GAACTCACACACAACACCA 19 
N/A 125 33662 33786 
10CpG_qPCR_R ACTCTGAATACCGACTCAAT 20 
15CpG_qPCR_F TATCACTGTTGATTCTCGC 19 
N/A 121 28669 28789 
15CpG_qPCR_R GGTAAAGAGTTTGGATTAGG 20 
20CpG_L_qPCR_F GGTGAACTTCCGATAGTG 18 
N/A 108 24202 24309 
20CpG_L_qPCR_R CAGTCATAGATGGTCGGT 18 
20CpG_S_qPCR_F GTTAGAGCCTGCATAACG 18 
N/A 109 44747 44855 
20CpG_S_qPCR_R GAAAGAGCACTGGCTAAC 18 
1CpG_F GAGGTGATAAAATTAACTGC 20 
0.5 197 23967 24163 
1CpG_R GGCTCTACCATATCTCCTA 19 
5CpG_F CATGTCCAGAGCTCATTC 18 
4.0 270 25869 26138 
5CpG_R GTTTAAAATCACTAGGCGA 19 
10CpG_F CTGACCATTTCCATCATTC 19 
5.6 360 33638 33997 
10CpG_R GTAACTAAACAGGAGCCG 18 
15CpG_F ATGTATCCATTGAGCATTGCC 21 
6.4 462 28488 28949 
15CpG_R CACGAATCAGCGGTAAAGGT 20 
20CpG_L_F GAGATATGGTAGAGCCGCAGA 21 8.0 275 24148 24643 
20CpG_L_R TTTCAGCAGCTACAGTCAGAATTT 24 
20CpG_S_F CGATGGGTTAATTCGCTCGTTGTGG 25 14.6 403 44589 44863 












 MM_meth_qPCR_R AACGACTTACAACGAGCTCAAA 22 
MM_unme_qPCR_F GGCTAGAACTGACCAGACAGAC 22 
16.0 86 Chr4:16751777   Chr4:16751862 








10.0 114 Chr22:29607176 Chr22:29607289 
HS_meth_qPCR_R TCGGTTAAAACGGTCAGGTC 18 
HS_unme_qPCR_F CGAGGCGTGAGTTATTCCTG 20 
10.0 110 Ch6:4011057 Chr6:4011166 





Step Problem Possible reason Solution 
31 No recovery of MeDIP fraction IP incubation time too short Increase IP incubation time 
  Ab AND/OR beads  Check all reagents have been correctly dispensed 
  Poor construction of control cocktail Check control cocktail sequences are methylated using methylation specific enzyme 
   Check control cocktail sequences amplify independently of MeDIP-seq experiment 
   Try using species-specific qPCR primers to validate recovery of MeDIP (expect 10-20% recovery) 
  None of the above? Repeat MeDIP on adapter-ligated DNA 
 Low (< 10%) recovery of MeDIP fraction and low (< 90%) 
specificity 
IP incubation time too short Increase IP incubation time  
  Aspiration of bead complex following IP (manual only) If beads remain in tips between MeDIP and purification, pipette mix the solution until no beads 
remain in the tip 
   None of the above? Repeat MeDIP on adapter ligated DNA 
 Low (< 10%) recovery but high (> 95%) specificity  IP incubation time too short but MeDIP should not be 
considered failed 
Proceed to amPCR (step 41) and evaluate  
 Ct values for both QC regions in MeDIP fraction are similar IP Incubation temperature too high Reduce IP incubation temperature to 4°C 
   Incorrect PCR product has been amplified Check qPCR melt curve 
37 No or very low post-amPCR yield Poor or very inefficient adapter ligation Check that peak size (assessed using Bioanalyzer) of fragments increases between sonication and 
adapter ligation 
   dilute post-adapter ligated samples 1 in 10 and perform a single amPCR reaction; should see a 
smear on a gel 
     Ensure samples have been purified prior to amPCR 
47 Little or no enrichment of methylated regions in MeDIP 
fraction 
PCR failure Check gel for DNA smear 
  Gel purification failure Ensure adequate volumes of Buffer QG are used 
   Ensure pH of QG & sample is at correct pH (< 7.5); if not add 10 µl 3 M NaAc (pH 5.0) 
  Inaccurate DNA quantification  Use Agilent High Sensitivity DNA chips. Avoid spectrophotometry 
  MeDIP and input sample concentrations not normalized Normalize MeDIP and Input sample concentrations to > 0.1 ng/µl 
  Poor starting DNA quality Ensure approximately 25-30% of starting  DNA falls into the desired excision range 
56 Low proportion of aligned reads Low quality base score at 3’ end of read Trim bases from the sequence prior to alignment 
    
  
